Funder
Polish National Science Centre
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Cavassin FB, Baú-Carneiro JL, Vilas-Boas RR, Queiroz-Telles F. Sixty years of amphotericin B: an overview of the Main Antifungal Agent used to treat invasive fungal infections. Infect Dis Ther. 2021;10(1):115–47.
2. Grela E, Piet M, Luchowski R, Grudzinski W, Paduch R, Gruszecki WI. Imaging of human cells exposed to an antifungal antibiotic amphotericin B reveals the mechanisms associated with the drug toxicity, and cell defence. Sci Rep. 2018;8(1):14067.
3. Carolus H, Pierson S, Lagrou K, Van Dijck P, Amphotericin B. Other Polyenes-Discovery, Clinical Use, Mode of Action, and Drug Resistance. J Fungi (Basel). 2020;6(4):321.
4. Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, et al. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases, and aging. Arch Toxicol. 2023;97(10):2499–574.
5. Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alex J Med. 2018;54(4):287–93.